316 related articles for article (PubMed ID: 15274074)
21. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.
Combs SE; Thilmann C; Edler L; Debus J; Schulz-Ertner D
J Clin Oncol; 2005 Dec; 23(34):8863-9. PubMed ID: 16314646
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase-2 in oligodendroglial neoplasms.
Castilla EA; Prayson RA; Kanner AA; Rybicki LA; Tubbs RR; Vogelbaum MA; Barnett GH
Cancer; 2003 Oct; 98(7):1465-72. PubMed ID: 14508834
[TBL] [Abstract][Full Text] [Related]
23. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
Kuan CT; Wakiya K; Dowell JM; Herndon JE; Reardon DA; Graner MW; Riggins GJ; Wikstrand CJ; Bigner DD
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1970-82. PubMed ID: 16609006
[TBL] [Abstract][Full Text] [Related]
24. Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas.
Zhen HN; Zhang X; Hu PZ; Yang TT; Fei Z; Zhang JN; Fu LA; He XS; Ma FC; Wang XL
Cancer; 2005 Dec; 104(12):2775-83. PubMed ID: 16284993
[TBL] [Abstract][Full Text] [Related]
25. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
26. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.
Rosenzweig T; Ziv-Av A; Xiang C; Lu W; Cazacu S; Taler D; Miller CG; Reich R; Shoshan Y; Anikster Y; Kazimirsky G; Sarid R; Brodie C
Cancer Res; 2006 Apr; 66(8):4139-48. PubMed ID: 16618735
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
[TBL] [Abstract][Full Text] [Related]
28. Final report on the University of California-San Francisco experience with bromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients.
Lamborn KR; Prados MD; Kaplan SB; Davis RL
Cancer; 1999 Feb; 85(4):925-35. PubMed ID: 10091772
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas.
Ali-Osman F; Brunner JM; Kutluk TM; Hess K
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2253-61. PubMed ID: 9815622
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival.
Li J; Guan HY; Gong LY; Song LB; Zhang N; Wu J; Yuan J; Zheng YJ; Huang ZS; Li M
Clin Cancer Res; 2008 Nov; 14(21):6996-7003. PubMed ID: 18980995
[TBL] [Abstract][Full Text] [Related]
31. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
[TBL] [Abstract][Full Text] [Related]
32. Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variables.
Zhou YH; Hess KR; Liu L; Linskey ME; Yung WK
Neuro Oncol; 2005 Oct; 7(4):485-94. PubMed ID: 16212813
[TBL] [Abstract][Full Text] [Related]
33. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
[TBL] [Abstract][Full Text] [Related]
34. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
35. Glioblastoma multiforme in skin: a report of 2 cases and review of the literature.
Mentrikoski M; Johnson MD; Korones DN; Scott GA
Am J Dermatopathol; 2008 Aug; 30(4):381-4. PubMed ID: 18645311
[TBL] [Abstract][Full Text] [Related]
36. [Immunohistochemical localization of fibronectin, laminin and fibronectin-receptor in human malignant gliomas--in relation to tumor invasion].
Higuchi M; Ohnishi T; Arita N; Hiraga S; Iwasaki H; Mori S; Hayakawa T
No To Shinkei; 1991 Jan; 43(1):17-23. PubMed ID: 1828988
[TBL] [Abstract][Full Text] [Related]
37. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated?
McLendon RE; Halperin EC
Cancer; 2003 Oct; 98(8):1745-8. PubMed ID: 14534892
[TBL] [Abstract][Full Text] [Related]
38. Erythropoietin receptor is expressed in meningiomas and lower levels are associated with tumour recurrence.
Küster O; Simon P; Mittelbronn M; Tabatabai G; Hermann C; Strik H; Dietz K; Roser F; Meyermann R; Schittenhelm J
Neuropathol Appl Neurobiol; 2009 Dec; 35(6):555-65. PubMed ID: 19298633
[TBL] [Abstract][Full Text] [Related]
39. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
40. VEGFR2 expression and TGF-β signaling in initial and recurrent high-grade human glioma.
Kuczynski EA; Patten SG; Coomber BL
Oncology; 2011; 81(2):126-34. PubMed ID: 21985798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
